Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.

By J. Parnell, R. Reimer. American Journal of Clinical Nutrition, 2009

723 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/7c82ad2840336afb41dfcbc1936d2a04f50c5c7a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Dietary prebiotics: current status and new definition (2010, background): “There is also interest in effects of prebiotics on lipid metabolism, immunomodulation of the gut immune system, glycaemic control, gut hormones, weight loss and satiety (Parnell and Reimer 2009), as well as behavioural effects and obesity.”
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health (2017, background): “[166] 48 healthy adults with a body mass index (in kg/m2) >25 OFS 12 weeks There was a reduction in body weight of 1.”
Impact of the gut microbiota on inflammation, obesity, and metabolic disease (2016, result): “Randomized controlled studies have identified surrogate markers of prebiotic treatment (such as plasma PYY, GLP-1, ghrelin) to be negatively correlated with weight gain, inflammation, and impaired glucose metabolism, which support the mechanisms observed in rodents [89, 90].”
Short chain fatty acids in human gut and metabolic health. (2020, unknown): “In line, Parnell and Reimer (2009) found reduced postprandial glucose and insulin levels and increased PYY levels after oligofructose (21 g/day) intake for 12 weeks in overweight adults.”
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics (2017, unknown): “The ability to enhance secretion of satiety hormones peptide YY and glucagon like peptide1 might be an associated attribute of prebiotic intervention and related SCFA production 74–76 .”
Gut Microbiota in Cardiovascular Health and Disease (2017, background): “Three months of oligofructose supplementation in patients with obesity was associated with weight loss and improved glucose tolerance.(174) In a preclinical study using an insulin resistance mouse model, use of antibiotics or prebiotics was reported to reverse microbial community features associated”